↓ Skip to main content

Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis

Overview of attention for article published in PLOS ONE, April 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

blogs
1 blog
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
109 Dimensions

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis
Published in
PLOS ONE, April 2008
DOI 10.1371/journal.pone.0001928
Pubmed ID
Authors

Friedemann Paul, Sonia Waiczies, Jens Wuerfel, Judith Bellmann-Strobl, Jan Dörr, Helmar Waiczies, Mareile Haertle, Klaus D. Wernecke, Hans-Dieter Volk, Orhan Aktas, Frauke Zipp

Abstract

Recent data from animal models of multiple sclerosis (MS) and from a pilot study indicated a possible beneficial impact of statins on MS.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Unknown 66 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 15%
Other 8 12%
Student > Ph. D. Student 8 12%
Student > Postgraduate 6 9%
Professor 5 7%
Other 19 28%
Unknown 11 16%
Readers by discipline Count As %
Medicine and Dentistry 28 42%
Agricultural and Biological Sciences 5 7%
Neuroscience 4 6%
Immunology and Microbiology 4 6%
Biochemistry, Genetics and Molecular Biology 3 4%
Other 8 12%
Unknown 15 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 May 2017.
All research outputs
#3,177,721
of 22,736,112 outputs
Outputs from PLOS ONE
#41,832
of 194,041 outputs
Outputs of similar age
#9,525
of 81,803 outputs
Outputs of similar age from PLOS ONE
#90
of 308 outputs
Altmetric has tracked 22,736,112 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 194,041 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.1. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 81,803 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 308 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.